129 related articles for article (PubMed ID: 9988848)
1. Schizophrenia, substance use, and brain morphology.
Scheller-Gilkey G; Lewine RR; Caudle J; Brown FW
Schizophr Res; 1999 Jan; 35(2):113-20. PubMed ID: 9988848
[TBL] [Abstract][Full Text] [Related]
2. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
Thoma P; Daum I
Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
[TBL] [Abstract][Full Text] [Related]
3. Double jeopardy: schizophrenia and substance use.
Swofford CD; Scheller-Gilkey G; Miller AH; Woolwine B; Mance R
Am J Drug Alcohol Abuse; 2000 Aug; 26(3):343-53. PubMed ID: 10976661
[TBL] [Abstract][Full Text] [Related]
4. The impact of substance use on brain structure in people at high risk of developing schizophrenia.
Welch KA; McIntosh AM; Job DE; Whalley HC; Moorhead TW; Hall J; Owens DG; Lawrie SM; Johnstone EC
Schizophr Bull; 2011 Sep; 37(5):1066-76. PubMed ID: 20223841
[TBL] [Abstract][Full Text] [Related]
5. Impulsivity-related brain volume deficits in schizophrenia-addiction comorbidity.
Schiffer B; Müller BW; Scherbaum N; Forsting M; Wiltfang J; Leygraf N; Gizewski ER
Brain; 2010 Oct; 133(10):3093-103. PubMed ID: 20647266
[TBL] [Abstract][Full Text] [Related]
6. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes.
Dixon L
Schizophr Res; 1999 Mar; 35 Suppl():S93-100. PubMed ID: 10190230
[TBL] [Abstract][Full Text] [Related]
7. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
8. Comorbid schizophrenia and substance abuse.
Green AI; Brown ES
J Clin Psychiatry; 2006 Sep; 67(9):e08. PubMed ID: 17081075
[TBL] [Abstract][Full Text] [Related]
9. Neural correlates of the affect regulation model in schizophrenia patients with substance use history: a functional magnetic resonance imaging study.
Mancini-Marïe A; Potvin S; Fahim C; Beauregard M; Mensour B; Stip E
J Clin Psychiatry; 2006 Mar; 67(3):342-50. PubMed ID: 16649818
[TBL] [Abstract][Full Text] [Related]
10. Substance abuse and schizophrenia: editors' introduction.
Kosten TR; Ziedonis DM
Schizophr Bull; 1997; 23(2):181-6. PubMed ID: 9165628
[TBL] [Abstract][Full Text] [Related]
11. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden.
Cantor-Graae E; Nordström LG; McNeil TF
Schizophr Res; 2001 Mar; 48(1):69-82. PubMed ID: 11278155
[TBL] [Abstract][Full Text] [Related]
12. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
Compton MT; Weiss PS; West JC; Kaslow NJ
Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
[TBL] [Abstract][Full Text] [Related]
13. Comorbid substance use disorders in schizophrenia: a latent class approach.
Kerner B
Psychiatry Res; 2015 Feb; 225(3):395-401. PubMed ID: 25576367
[TBL] [Abstract][Full Text] [Related]
14. Long-term Administration of Antipsychotic Drugs in Schizophrenia and Influence of Substance and Drug Abuse on the Disease Outcome.
Werner FM; Covenas R
Curr Drug Abuse Rev; 2017; 10(1):19-24. PubMed ID: 29065847
[TBL] [Abstract][Full Text] [Related]
15. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
16. Patterns of current and lifetime substance use in schizophrenia.
Fowler IL; Carr VJ; Carter NT; Lewin TJ
Schizophr Bull; 1998; 24(3):443-55. PubMed ID: 9718636
[TBL] [Abstract][Full Text] [Related]
17. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
Green AI
J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
[TBL] [Abstract][Full Text] [Related]
18. Effects of psychoactive substances in schizophrenia -- findings of structural and functional neuroimaging.
Walter M; Denier N; Vogel M; Lang UE
Curr Top Med Chem; 2012; 12(21):2426-33. PubMed ID: 23279181
[TBL] [Abstract][Full Text] [Related]
19. Substance abuse in schizophrenia. A Singapore perspective.
Verma SK; Subramaniam M; Chong SA; Kua EH
Soc Psychiatry Psychiatr Epidemiol; 2002 Jul; 37(7):326-8. PubMed ID: 12111024
[TBL] [Abstract][Full Text] [Related]
20. [Cannabis and schizophrenia: demographic and clinical correlates].
Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
